SPOT-mRNA01
SPOT-mRNA01 is an emerging mRNA-based therapy designed to modulate immune responses. Its primary mechanism involves using synthetic mRNA to instruct cells to produce specific proteins that can enhance or regulate immune function. This approach holds potential for longevity and health optimization by potentially improving immune resilience and targeting age-related immune decline.
Member access required
Clinical protocols and outcomes data are available to AXIFI Members and Providers.